News FDA approves Pfizer's Besponsa in aggressive blood cancer Besponsa becomes first of its kind indicated for rare type of acute lymphoblastic leukaemia.
News Real world data essential for CAR-T therapy success Innovators will need to quantify value to bring costly drugs to market.
News Kite files CAR-T therapy in EU, ahead of Novartis rival Kite eyes possible CAR-T launch next year.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
